MANU OHRI
Corporate Board Profile
Tech Score:
0
/100
← Back to All Directors
GT Biopharma, Inc.
Filing Date
Source Excerpt
2022-08-17
Manu Ohri
2023-11-06
Manu Ohri (2) Includes shares underlying options to purchase 591,666 shares of common stock.
Data sourced from SEC filings. Last updated: 2025-08-30